Back to search
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open-label, randomized, multi-center phase II study to evaluate the safety, tolerability, PK, and efficacy of SHR-4602 monotherapy in subjects with H…
The objective of this study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of BL-M17D1 in patients with HER2-Expressing or HER2-Mutant Adv…